UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 381

Sortiert nach

Proton Pump Inhibitor (PPI) Therapy Does Not Affect SVR Rates Among Patients Treated With Ledipasvir/Sofosbuvir Combination Therapy: 954

The American journal of gastroenterology, 2017, Vol.112, p.S535

2017

Volltextzugriff (PDF)

ε-MnO2-modified graphite electrode as a novel electrochemical sensor for the ultrasensitive detection of the newly FDA approved Hepatitis C antiviral drug ledipasvir

Analytica chimica acta, 2018-12, Vol.1038, p.29-40

2018

Volltextzugriff (PDF)

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Journal of hepatology, 2016-06, Vol.64 (6), p.1224-1231

2016

Volltextzugriff (PDF)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

Journal of hepatology, 2016-10, Vol.65 (4), p.741-747

2016

Volltextzugriff (PDF)

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates [version 2; peer review: 3 approved]

F1000 research, 2020, Vol.9, p.129

2020

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure: A Case Report

Internal Medicine, 2020, pp.2982-19

2020

Volltextzugriff (PDF)

Eco friendly stability indicating HPTLC method for simultaneous determination of sofosbuvir and ledipasvir in pharmaceutical tablets and HPTLC-MS characterization of their degradation products

Microchemical journal, 2023-03, Vol.186, p.108324, Article 108324

2023

Volltextzugriff (PDF)

Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

The Korean journal of internal medicine, 2022-11, Vol.37 (6), p.1167-1175

2022

Volltextzugriff (PDF)

A dispersive liquid–liquid microextraction method based on solidification of floating organic droplet for determination of antiviral agents in environmental water using HPLC/UV

Microchemical journal, 2021-12, Vol.171, p.106790, Article 106790

2021

Volltextzugriff (PDF)

Innovative derivative/zero ratio spectrophotometric method for simultaneous determination of sofosbuvir and ledipasvir: Application to average content and uniformity of dosage units

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022-02, Vol.267, p.120623, Article 120623

2022

Volltextzugriff (PDF)

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

Journal of hepatology, 2017-05, Vol.66 (5), p.910-918

2017

Volltextzugriff (PDF)

Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct‐acting antivirals

Journal of viral hepatitis, 2018-07, Vol.25 (7), p.870-873

2018

Volltextzugriff (PDF)

Computational design for eco-friendly visible spectrophotometric platform used for the assay of the antiviral agent in pharmaceutical dosage form

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022-04, Vol.271, p.120897, Article 120897

2022

Volltextzugriff (PDF)

Impact of sofosbuvir/ledipasvir versus sofosbuvir/daclatasvir regimens on the male sexual function of patients with chronic hepatitis C

Le infezioni in medicina, 2021, Vol.29 (3), p.456-463

2021

Volltextzugriff (PDF)

Effectiveness of hepatitis c antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma

Journal of hepatology, 2017-07, Vol.67 (1), p.32-39

2017

Volltextzugriff (PDF)

Ledipasvir/Sofosbuvir is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir

Internal Medicine, 2023, pp.0865-22

2023

Volltextzugriff (PDF)

Green RP-HPLC method for simultaneous determination of sofosbuvir, ledipasvir, velpatasvir antivirals and beyond in their bulk material and co-formulated products

Microchemical journal, 2023-03, Vol.186, p.108344, Article 108344

2023

Volltextzugriff (PDF)

A facile synthesis of 3D NiFe2O4 nanospheres anchored on a novel ionic liquid modified reduced graphene oxide for electrochemical sensing of ledipasvir: Application to human pharmacokinetic study

Biosensors & bioelectronics, 2018-06, Vol.109, p.164-170

2018

Volltextzugriff (PDF)

Validated 1H and 19F nuclear magnetic resonance for the quantitative determination of the hepatitis C antiviral drugs sofosbuvir, ledipasvir, and daclatasvir in tablet dosage forms

Microchemical journal, 2020-01, Vol.152, p.104437, Article 104437

2020

Volltextzugriff (PDF)

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Gastroenterology (New York, N.Y. 1943), 2016-12, Vol.151 (6), p.1131-1140.e5

2016

Volltextzugriff (PDF)

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

Therapeutic Advances in Gastroenterology, 2015-09, Vol.8 (5), p.298-312

2015

Volltextzugriff (PDF)

Green analytical method for the determination of sofosbuvir, ledipasvir, ribavirin and complex silymarin flavonoids simultaneously in biological fluids

Microchemical journal, 2021-05, Vol.164, p.105964, Article 105964

2021

Volltextzugriff (PDF)

Sustained Viral Response in Genotype 4 Chronic Hepatitis C Virus–infected Children and Adolescents Treated With Sofosbuvir/Ledipasvir

Journal of pediatric gastroenterology and nutrition, 2018-11, Vol.67 (5), p.626-630

2018

Volltextzugriff (PDF)

Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and/or ledipasvir utilizing direct and H-point standard addition strategies

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2019-03, Vol.210, p.290-297

2019

Volltextzugriff (PDF)

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

Liver international, 2016-01, Vol.36 (S1), p.47-57

2016

Volltextzugriff (PDF)

1 – 25 von 381

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(330)
Mit Volltextzugriff
(338)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(311)
Life Sciences & Biomedicine
(284)
Ledipasvir
(282)
Sofosbuvir
(256)
Humans
(187)
Hepatitis C
(172)
Hepatitis C, Chronic - Drug Therapy
(123)
Antiviral Agents - Therapeutic Use
(117)
Hepatitis C Virus
(116)
Gastroenterology & Hepatology
(107)
Male
(101)
Female
(96)
Hepatitis
(92)
Middle Aged
(87)
Hepacivirus - Genetics
(82)
Daclatasvir
(79)
Drug Therapy, Combination
(79)
Fluorenes - Therapeutic Use
(79)
Benzimidazoles - Therapeutic Use
(76)
Ribavirin
(75)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Proton Pump Inhibitor (PPI) Therapy Does Not Affect SVR Rates Among Patients Treated With Ledipasvir/Sofosbuvir Combination Therapy: 954

ε-MnO2-modified graphite electrode as a novel electrochemical sensor for the ultrasensitive detection of the newly FDA approved Hepatitis C antiviral drug ledipasvir

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates [version 2; peer review: 3 approved]

Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure: A Case Report

Eco friendly stability indicating HPTLC method for simultaneous determination of sofosbuvir and ledipasvir in pharmaceutical tablets and HPTLC-MS characterization of their degradation products

Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

A dispersive liquid–liquid microextraction method based on solidification of floating organic droplet for determination of antiviral agents in environmental water using HPLC/UV

Innovative derivative/zero ratio spectrophotometric method for simultaneous determination of sofosbuvir and ledipasvir: Application to average content and uniformity of dosage units

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct‐acting antivirals

Computational design for eco-friendly visible spectrophotometric platform used for the assay of the antiviral agent in pharmaceutical dosage form

Impact of sofosbuvir/ledipasvir versus sofosbuvir/daclatasvir regimens on the male sexual function of patients with chronic hepatitis C

Effectiveness of hepatitis c antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma

Ledipasvir/Sofosbuvir is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir

Green RP-HPLC method for simultaneous determination of sofosbuvir, ledipasvir, velpatasvir antivirals and beyond in their bulk material and co-formulated products

A facile synthesis of 3D NiFe2O4 nanospheres anchored on a novel ionic liquid modified reduced graphene oxide for electrochemical sensing of ledipasvir: Application to human pharmacokinetic study

Validated 1H and 19F nuclear magnetic resonance for the quantitative determination of the hepatitis C antiviral drugs sofosbuvir, ledipasvir, and daclatasvir in tablet dosage forms

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

Green analytical method for the determination of sofosbuvir, ledipasvir, ribavirin and complex silymarin flavonoids simultaneously in biological fluids

Sustained Viral Response in Genotype 4 Chronic Hepatitis C Virus–infected Children and Adolescents Treated With Sofosbuvir/Ledipasvir

Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and/or ledipasvir utilizing direct and H-point standard addition strategies

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

Suchergebnisse filtern